HomeSLNO • NASDAQ
add
Soleno Therapeutics Inc
Previous close
$58.34
Day range
$57.85 - $58.88
Year range
$26.38 - $60.92
Market cap
2.51B USD
Avg Volume
578.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 79.34M | 747.51% |
Net income | -76.62M | -605.42% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -78.84M | -788.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 256.78M | 389.68% |
Total assets | 296.71M | 366.90% |
Total liabilities | 32.01M | -20.63% |
Total equity | 264.70M | — |
Shares outstanding | 43.12M | — |
Price to book | 9.04 | — |
Return on assets | -66.02% | — |
Return on capital | -72.28% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -76.62M | -605.42% |
Cash from operations | -14.93M | -135.72% |
Cash from investing | 4.04M | — |
Cash from financing | 2.28M | -94.23% |
Net change in cash | -8.61M | -126.04% |
Free cash flow | 12.94M | -23.44% |
About
Founded
1999
Headquarters
Website
Employees
33
